BibTex format
@article{Clamp:2019:10.1016/S0140-6736(19)32259-7,
author = {Clamp, AR and James, EC and McNeish, IA and Dean, A and Kim, J-W and O'Donnell, DM and Hook, J and Coyle, C and Blagden, S and Brenton, JD and Naik, R and Perren, T and Sundar, S and Cook, AD and Gopalakrishnan, GS and Gabra, H and Lord, R and Dark, G and Earl, HM and Hall, M and Banerjee, S and Glasspool, RM and Jones, R and Williams, S and Swart, AM and Stenning, S and Parmar, M and Kaplan, R and Ledermann, JA},
doi = {10.1016/S0140-6736(19)32259-7},
journal = {The Lancet},
pages = {2084--2095},
title = {Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial},
url = {http://dx.doi.org/10.1016/S0140-6736(19)32259-7},
volume = {394},
year = {2019}
}